Boston's biotech gender gap is narrowing — but far too slowly

From the viewpoints of several young women interviewed for this article, efforts to get more woman into senior roles at biotech and life sciences are still moving far too slowly.

​Biogen CEO George Scangos to step down, search for successor to begin

The CEO of Biogen for the past six years says he’s stepping down to return to the West Coast and spend time with his family.

Harvard Biosciences CEO Jeff Duchemin relies on lessons from the gridiron

His leadership role on the field, he says, helped prepare him to run a 475-employee company.

Two years later, revisiting my ‘Six drugs that could change the world’

In September 2014 I named an anti-obesity drug by Zafgen one of “Six drugs that could change the world.” Here's where those drugs are two years later.

MilliporeSigma’s planned $115M Burlington office highlights company's global plans

Boston Business Journal Science & Tech Newsletters